These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1521 related items for PubMed ID: 19719543

  • 1. Topiramate treatment of chronic migraine: a randomized, placebo-controlled trial of quality of life and other efficacy measures.
    Silberstein S, Lipton R, Dodick D, Freitag F, Mathew N, Brandes J, Bigal M, Ascher S, Morein J, Wright P, Greenberg S, Hulihan J.
    Headache; 2009 Sep; 49(8):1153-62. PubMed ID: 19719543
    [Abstract] [Full Text] [Related]

  • 2. Topiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs.
    Dodick DW, Freitag F, Banks J, Saper J, Xiang J, Rupnow M, Biondi D, Greenberg SJ, Hulihan J, CAPSS-277 Investigator Group.
    Clin Ther; 2009 Mar; 31(3):542-59. PubMed ID: 19393844
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.
    Silberstein SD, Lipton RB, Dodick DW, Freitag FG, Ramadan N, Mathew N, Brandes JL, Bigal M, Saper J, Ascher S, Jordan DM, Greenberg SJ, Hulihan J, Topiramate Chronic Migraine Study Group.
    Headache; 2007 Feb; 47(2):170-80. PubMed ID: 17300356
    [Abstract] [Full Text] [Related]

  • 4. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.
    Diener HC, Bussone G, Van Oene JC, Lahaye M, Schwalen S, Goadsby PJ, TOPMAT-MIG-201(TOP-CHROME) Study Group.
    Cephalalgia; 2007 Jul; 27(7):814-23. PubMed ID: 17441971
    [Abstract] [Full Text] [Related]

  • 5. The impact of topiramate on health-related quality of life indicators in chronic migraine.
    Dodick DW, Silberstein S, Saper J, Freitag FG, Cady RK, Rapoport AM, Mathew NT, Hulihan J, Crivera C, Rupnow MF, Mao L, Finlayson G, Greenberg SJ.
    Headache; 2007 Jul; 47(10):1398-408. PubMed ID: 18052949
    [Abstract] [Full Text] [Related]

  • 6. The impact of migraine on daily activities: effect of topiramate compared with placebo.
    Silberstein SD, Loder E, Forde G, Papadopoulos G, Fairclough D, Greenberg S.
    Curr Med Res Opin; 2006 Jun; 22(6):1021-9. PubMed ID: 16846536
    [Abstract] [Full Text] [Related]

  • 7. Assessing the ability of topiramate to improve the daily activities of patients with migraine.
    Brandes JL, Kudrow DB, Rothrock JF, Rupnow MF, Fairclough DL, Greenberg SJ.
    Mayo Clin Proc; 2006 Oct; 81(10):1311-9. PubMed ID: 17036556
    [Abstract] [Full Text] [Related]

  • 8. Topiramate in migraine prevention: results of a large controlled trial.
    Silberstein SD, Neto W, Schmitt J, Jacobs D, MIGR-001 Study Group.
    Arch Neurol; 2004 Apr; 61(4):490-5. PubMed ID: 15096395
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and tolerability of topiramate 200 mg/d in the prevention of migraine with/without aura in adults: a randomized, placebo-controlled, double-blind, 12-week pilot study.
    Silberstein SD, Hulihan J, Karim MR, Wu SC, Jordan D, Karvois D, Kamin M.
    Clin Ther; 2006 Jul; 28(7):1002-11. PubMed ID: 16990078
    [Abstract] [Full Text] [Related]

  • 10. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R, Schreiber C.
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [Abstract] [Full Text] [Related]

  • 11. Topiramate intervention to prevent transformation of episodic migraine: the topiramate INTREPID study.
    Lipton RB, Silberstein S, Dodick D, Cady R, Freitag F, Mathew N, Biondi DM, Ascher S, Olson WH, Hulihan J.
    Cephalalgia; 2011 Jan; 31(1):18-30. PubMed ID: 20974598
    [Abstract] [Full Text] [Related]

  • 12. Topiramate for migraine prevention in children: a randomized, double-blind, placebo-controlled trial.
    Winner P, Pearlman EM, Linder SL, Jordan DM, Fisher AC, Hulihan J, Topiramate Pediatric Migraine Study Investigators.
    Headache; 2005 Jan; 45(10):1304-12. PubMed ID: 16324162
    [Abstract] [Full Text] [Related]

  • 13. Topiramate and triptans revert chronic migraine with medication overuse to episodic migraine.
    Mei D, Ferraro D, Zelano G, Capuano A, Vollono C, Gabriele C, Di Trapani G.
    Clin Neuropharmacol; 2006 Jan; 29(5):269-75. PubMed ID: 16960472
    [Abstract] [Full Text] [Related]

  • 14. Topiramate for migraine prevention: a randomized controlled trial.
    Brandes JL, Saper JR, Diamond M, Couch JR, Lewis DW, Schmitt J, Neto W, Schwabe S, Jacobs D, MIGR-002 Study Group.
    JAMA; 2004 Feb 25; 291(8):965-73. PubMed ID: 14982912
    [Abstract] [Full Text] [Related]

  • 15. Topiramate improves health-related quality of life when used to prevent migraine.
    Diamond M, Dahlöf C, Papadopoulos G, Neto W, Wu SC.
    Headache; 2005 Sep 25; 45(8):1023-30. PubMed ID: 16109116
    [Abstract] [Full Text] [Related]

  • 16. Long-term migraine prevention with topiramate: open-label extension of pivotal trials.
    Rapoport A, Mauskop A, Diener HC, Schwalen S, Pfeil J.
    Headache; 2006 Sep 25; 46(7):1151-60. PubMed ID: 16866719
    [Abstract] [Full Text] [Related]

  • 17. Effect of early intervention with almotriptan vs placebo on migraine-associated functional disability: results from the AEGIS Trial.
    Freitag F, Smith T, Mathew N, Rupnow M, Greenberg S, Mao L, Finlayson G, Wright P, Biondi D, AEGIS Investigator Study Group.
    Headache; 2008 Mar 25; 48(3):341-54. PubMed ID: 18302700
    [Abstract] [Full Text] [Related]

  • 18. Topiramate for migraine prevention in a naturalistic setting: results from an open label, flexible dose study.
    Nelles G, Delbrück A, Schulze L, Kademann B, Bornhoevd K, Schäfer S, Schäuble B, TOPMAT-MIG-4009 investigators.
    Headache; 2009 Mar 25; 49(10):1454-65. PubMed ID: 19804392
    [Abstract] [Full Text] [Related]

  • 19. The impact of migraine prevention on daily activities: a longitudinal and responder analysis from three topiramate placebo-controlled clinical trials.
    Dahlöf C, Loder E, Diamond M, Rupnow M, Papadopoulos G, Mao L.
    Health Qual Life Outcomes; 2007 Oct 04; 5():56. PubMed ID: 17916258
    [Abstract] [Full Text] [Related]

  • 20. Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.
    Aurora SK, Gawel M, Brandes JL, Pokta S, Vandenburgh AM, BOTOX North American Episodic Migraine Study Group.
    Headache; 2007 Apr 04; 47(4):486-99. PubMed ID: 17445098
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 77.